☆ 3.8 Article

Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis

CANCER RESEARCH COMMUNICATIONS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States

Mohammad A. Karim et al.

Summary: NAFLD is the leading cause of HCC among Medicare beneficiaries, accounting for 35.6% of cases. Compared to HCC related to hepatitis C, NAFLD-associated HCC had lower surveillance receipt, later stage detection, and slightly poorer survival. Multifaceted interventions are needed to improve surveillance uptake and prognosis for NAFLD-related HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Risk stratification and early detection biomarkers for precision HCC screening

Yi-Te Lee et al.

Summary: Hepatocellular carcinoma (HCC) mortality remains high due to late diagnosis, but traditional screening approaches may not be practical in the face of shifting disease etiologies. New modalities and strategies are urgently needed to improve early HCC detection.

HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

Neehar D. Parikh et al.

Summary: Hepatocellular carcinoma (HCC) is a major contributor to cancer-related deaths globally due to inadequate early detection strategies. Current screening recommendations have several deficiencies, including suboptimal sensitivity and poor adherence. Blood-based biomarkers show promise but require validation and logistical solutions before clinical implementation. Maturing validation cohorts, such as the Hepatocellular Carcinoma Early Detection Study and the Texas Hepatocellular Carcinoma Consortium, are expected to provide robust validation for candidate biomarkers.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

Amit G. Singal et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis with survival rates below 20% in 5 years, partly due to failures in the cancer screening process continuum. A conceptual model outlining discrete steps in the HCC screening process highlights delays or failures at each step and identifies factors contributing to these failures at the patient, provider, and health care system levels. Comparing HCC screening processes with breast and colorectal cancer screening can help identify opportunities for improvement and ultimately improve early detection of HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study

Nicolas Chong et al.

Summary: This study found that impaired ultrasound visualization is associated with worse surveillance test performance in patients with cirrhosis. Severe visual limitations were linked to lower sensitivity, while moderate limitations were associated with an increased risk of false-positive results. Alternative blood-based biomarkers and imaging strategies are needed for patients at risk of ultrasound-based surveillance failure.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

Sumeet K. Asrani et al.

Summary: The American Association for the Study of Liver Diseases (AASLD) Practice Metrics Committee developed a standardized set of process-based measures and patient-reported outcomes (PROs) for hepatocellular carcinoma (HCC) care to bridge the gap between guideline recommendations and measurable processes and outcomes for this high-risk population.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Amit G. Singal et al.

Summary: In this systematic review and meta-analysis, HCC surveillance was found to be associated with improved early-stage detection, curative treatment receipt, and survival in patients with cirrhosis. However, there was significant heterogeneity in the pooled estimates, and there were fewer data quantifying potential surveillance-related harms. Available data suggest that HCC surveillance is of high value in patients with cirrhosis, although further studies evaluating benefits and harms are still needed.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients

Hyo Jung Park et al.

Summary: By comparing the performance of gadoxetic acid-enhanced abbreviated MRI (AMRI)-based surveillance and ultrasound-only surveillance in high-risk patients for hepatocellular carcinoma (HCC), it was found that AMRI-based surveillance had higher sensitivities and accuracies for early-stage HCC than ultrasound-only surveillance.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Haley Schoenberger et al.

Summary: Nearly 1 in 5 patients with cirrhosis had moderately-severely limited ultrasound visualization for HCC nodules, particularly those with obesity or alcohol-related or nonalcoholic fatty liver disease cirrhosis. Ultrasound quality can change between exams, including improvement in many patients with limited visualization.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort

Neehar D. Parikh et al.

Summary: This cohort study reveals that HCC surveillance is underused in more than 80% of cirrhosis patients, leading to failures in the screening process. Dedicated programs are needed to improve cirrhosis detection and HCC surveillance.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

Pierre Nahon et al.

Summary: This study aimed to evaluate the cost-effectiveness of using magnetic resonance imaging (MRI) for the detection of very early hepatocellular carcinoma (HCC) in French patients with an annual HCC risk >3%. The results showed that MRI was cost-effective in this population and could favor early HCC detection.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma

Nikita Sandeep Wagle et al.

Summary: The study revealed significant disparities in curative treatment receipt and overall survival between Black and White patients with HCC, particularly pronounced among those living in high-poverty neighborhoods. In contrast, Hispanic and Asian patients showed similar rates of curative treatment utilization compared to White patients across all socioeconomic levels.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis

Erin Wolf et al.

Summary: The study found that HCC surveillance is underused in clinical practice, especially among patients with alcohol-associated or NASH-related cirrhosis and those not followed in subspecialty gastroenterology clinics. Interventions such as provider education, inreach including reminder systems, and population health outreach efforts can significantly increase HCC surveillance.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: In a cohort of patients with cirrhosis, HCC surveillance was associated with high early tumor detection and minimal physical harms.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Jennifer S. Lin et al.

Summary: There are multiple screening options for colorectal cancer, each with varying levels of evidence in reducing cancer mortality, detecting cancer or precursor lesions, and risks of harms. This systematic review summarizes published evidence on the benefits and harms of screening for colorectal cancer in asymptomatic, community-dwelling adults to support the 2021 US Preventive Services Task Force Recommendation Statement.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis

Patrick Marquardt et al.

Summary: The main reasons for underuse of HCC screening in patients with cirrhosis are lack of regular outpatient care and lack of screening orders in those with known cirrhosis, highlighting the need for interventions at these steps to increase HCC screening utilization.

HEPATOLOGY COMMUNICATIONS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis

Nicole E. Rich et al.

HEPATOLOGY (2020)

添加到收藏夹

Article Oncology

Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening

Caitlin C. Murphy et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

添加到收藏夹

Article Oncology

A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development

Jeong Hee Yoon et al.

LIVER CANCER (2020)

添加到收藏夹

Article Oncology

Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma

Caitlin A. Hester et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis

Debra T. Choi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis

Hye-Lin Kim et al.

HEPATOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

Lewis R. Roberts et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Kristina Tzartzeva et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis

O. Simmons et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis

Omair Atiq et al.

HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota A US Population-based Study

Ju Dong Yang et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance

Nicole E. Rich et al.

SEMINARS IN LIVER DISEASE (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

Nicolas Goossens et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

添加到收藏夹

Article Oncology

MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma

So Yeon Kim et al.

JAMA ONCOLOGY (2017)

添加到收藏夹

Letter Gastroenterology & Hepatology

Lead time bias in estimating survival outcomes

Antonio Facciorusso et al.

GUT (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer

M. Walker et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study

Hla-Hla Thein et al.

PLOS ONE (2015)

添加到收藏夹

Article Medicine, General & Internal

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

Amit G. Singal et al.

PLOS MEDICINE (2014)

添加到收藏夹

Review Oncology

The benefits and harms of breast cancer screening: an independent review

M. G. Marmot et al.

BRITISH JOURNAL OF CANCER (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA

Hashem B. El-Serag et al.

GUT (2011)

添加到收藏夹

Article Public, Environmental & Occupational Health

Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival

Stephen W. Duffy et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

添加到收藏夹

Article Gastroenterology & Hepatology

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

J. R. Kramer et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.